accelerating neural imaging through AI optimization.

Published Date: 15 Nov 2023

There's been a surge in interest in connectomics, the ambitious field of study that aims to map the complex network of animal brains. It has progressed from its early stages to a discipline that in just ten years.

Read Full News

Latest News

Age-Specific Needs in Young Women With Breast Cancer

Drs Olivia Pagani and Ann Partridge discuss how to optimize the care plan for young patients with breast cancer, focusing on age-specific concerns such as fertility and long-term survivorship.

Amantadine Awakens 94-Year-Old Woman After Stroke

A short amantadine course produced eye opening and tracking within 24 hours and a GCS of 14-15 by day 4 in a case of prolonged nontraumatic impaired consciousness.

Advances in Chronic Rhinosinusitis From ARS 2026

Advances in chronic rhinosinusitis from ARS 2026 include data on biologics vs surgery rates, AI tools in clinic, and wearable tech to document clinical efficacy, as reported by Dr Vijay Ramakrishnan.

Anticipating Key Early Breast Cancer Research at ASCO 2026

Dr Bora Lim anticipates new data on bispecific antibodies and CDK4 inhibitors, as well as crucial updates on ADCs and ctDNA-guided treatments.

May 15 2026 This Week in Cardiology

Another positive digoxin trial, another classic coronary physiology study from Imperial College London (ORBITA-FIRE), news in hypertrophic cardiomyopathy, and TAVR done in the wrong patients are the topics John Mandrola, MD, discusses in this week’s podcast.

Inside OCT and IVUS: AI’s New Edge in PCI

From automatic calcium and lipid detection to post-stent expansion checks, learn how AI helps close the gap between novice and expert and why that matters for outcomes.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

Drs Olivia Pagani and Ann Partridge discuss how to optimize the care plan for young patients with breast cancer, focusing on age-specific concerns such as fertility and long-term survivorship.

A short amantadine course produced eye opening and tracking within 24 hours and a GCS of 14-15 by day 4 in a case of prolonged nontraumatic impaired consciousness.

Advances in chronic rhinosinusitis from ARS 2026 include data on biologics vs surgery rates, AI tools in clinic, and wearable tech to document clinical efficacy, as reported by Dr Vijay Ramakrishnan.

Dr Bora Lim anticipates new data on bispecific antibodies and CDK4 inhibitors, as well as crucial updates on ADCs and ctDNA-guided treatments.

Another positive digoxin trial, another classic coronary physiology study from Imperial College London (ORBITA-FIRE), news in hypertrophic cardiomyopathy, and TAVR done in the wrong patients are the topics John Mandrola, MD, discusses in this week’s podcast.

From automatic calcium and lipid detection to post-stent expansion checks, learn how AI helps close the gap between novice and expert and why that matters for outcomes.

News All Time

Beware of Radiation Doses Among Heart Scanners, Study Says

Coronary CT angiography, poorer countries under scrutiny for larger doses

Reining in Overdiagnosis of Papillary Thyroid Cancer: Easier Said Than Done

Cutting ultrasound referrals for nonpalpable nodules could lead to decreases in incidence

Should We Do a Shoulder MRI? Food Prescriptions for Diabetes

Also in TTHealthWatch: a planetary health diet, and patient views of statin therapy

Lead Suits Cut Physician Radiation Exposure for Interventional Cardiology Cases

Median exposure reduced to 0 versus lead apron during LAAO, with possible broader applicability

Routine Mammograms That Also Flag CVD: Two Birds With One Stone?

AI-driven quantification of breast arterial calcification on imaging could ID higher-risk women

Even Patients Are Shocked by the Prices Their Insurers Will Pay

And it costs all of us

Tiny Blood Smidges in the Brain: Amount and Location Tied to Dementia

Neuroimaging findings believed to arise from distinct pathologies

Deepfake X-Rays Sneak Past Radiologists and AI, Underscoring Abuse Potential

Unaware they were looking at phony images, a majority of radiologists judged fakes as real

Ultrasound Treatment for Prostate Cancer Has Early Advantage Versus Prostatectomy

Better continence, erectile function, but data on oncologic outcomes still 2 years away

AI Strategy Could Eliminate Radiologist Review of Low-Risk Mammograms

Approach cut workload by 64% and increased cancer detection rate versus standard strategy

PSMA-PET Cuts Need for Biopsy in Suspected Prostate Cancer

But does it cost too much?

Quiz Time: Can Radiologists Spot AI Deepfakes?

You passed medical training, now see if you can pass our weekly quiz

Low Breast Cancer Recurrence Rate With Radiotherapy Tailored to Nodal Response

Locoregional recurrence rate of 2.9% overall with no variation across node-defined risk groups

Mammography Use Declined Among Younger Women in Recent Years

Decline follows the 2009 change to USPSTF guidelines for women ages 40 to 49

False-Negative CAC Findings That Equal Zero Cluster in Certain Groups, Study Finds

Race/ethnicity and country important to consider when interpreting coronary artery calcium score

Replace Yourself With AI, CEO Katz

Let's test out this new tech where the downside is a bad spreadsheet, not a missed cancer

Recommended News For You

CDC Alerts on Dramatic Rise in Human Parvovirus B19

What Patients Hear From Us: 'Blah, Blah, Tumor, Blah, Blah, Cancer'

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.

Recommended Articles For You

Understanding Macrocytosis: Causes, Symptoms, and Treatment Options  

Unlocking the Mysteries of ICD 10 Code Normocytic Anemia 

Unlocking the Mystery of Ovarian Cancer Staging 

Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

3.

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

4.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

5.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.

1.

The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy

2.

The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond

3.

Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense

4.

New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results

5.

Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

2.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

5.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot